What's breaking now, across thousands of outlets.
The Trump administration is expanding Medicare’s new technology-based payment experiment to cover more chronic conditions, including COPD, substance use disorder and tobacco cessation.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Non-medical managers are the only safety-critical part of the service that do not have a regulator. Lady Justice Thirlwall says that must change.
The co-branded plans will be available to more than 2 million Medicare enrollees in two states when open enrollment begins Oct. 15
Researchers are raising concerns about the promotion of Alzheimer's disease blood tests on social media, particularly posts making claims that do not align with current clinical recommendations.
The FDA is opening applications for a pilot program designed to shorten the time it takes for drugmakers to begin testing their products in humans
Sanofi has officially opened a massive new flu‑vaccine manufacturing facility in Toronto — a $925‑million project billed as the largest single bio-manufacturing investment in Canadian history.
Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma.
